You can lose a significant amount of weight on Ozempic, but the range is wide and depends heavily on dose, time, and your own habits. In clinical studies of semaglutide (the active ingredient in Ozempic and Wegovy), people with obesity often lost around 10–15% of their body weight over about 1 to 1.5 years when medication was combined with diet and exercise.

Quick Scoop

  • Typical clinical-trial averages for semaglutide: about 10–15% body weight loss over 68 weeks (around 1.3 years).
  • Real-world results vary a lot: some people lose just a few kilos, others 20+ kg over a year or more.
  • Ozempic itself is approved for diabetes , not weight loss; Wegovy (same drug, higher dose) is the one approved specifically for obesity.
  • You usually lose weight gradually , with more obvious changes after the first 3–6 months if your dose is optimized and lifestyle changes are in place.
  • The medication works while you’re on it ; stopping suddenly often leads to regaining some or much of the weight if habits and support don’t change.

What studies say about “how much”

Most of the best data comes from trials of semaglutide 2.4 mg (the Wegovy dose), but it gives a good ballpark for what this drug class can do. Think of these as averages, not promises.

Trial-level results

  • In a landmark 68‑week trial of semaglutide in people with overweight/obesity plus lifestyle changes:
    • Average loss was about 15% of starting body weight.
* For someone at 100 kg, that’s roughly **15 kg** over about a year and a bit.
* Many participants lost around **10–20%** , but some lost less and some more.
  • GLP‑1 drugs like Ozempic/Wegovy typically lead to about 15–20% weight loss on average with ongoing treatment at higher doses in obesity care settings.

These are structured research environments, with coaching on diet and exercise built in. Real life usually looks messier—illness, stress, inconsistent dosing, and food environment all change the outcome.

Real-world: what people report

On forums and support communities, people share very mixed numbers.

Common patterns you’ll see:

  • First 1–3 months:
    • Some people report 5–7 kg or more in the first few months, especially at higher doses and with big appetite changes.
* Others lose only a couple of kilos early, then speed up when dose increases.
  • First 6–12 months:
    • Many posts talk about double‑digit kilo losses (10–20+ kg) over 6–12 months when they stay on the medicine and adjust diet.
* Some people stall or lose very slowly and need dose adjustments, nutrition tweaks, or added activity.

You’ll also see people pointing out that “average weight loss” is almost meaningless without context, because it depends on where you start, your dose, and your lifestyle.

Key factors that change “how much”

How much weight you can lose on Ozempic isn’t fixed; it’s more like a range with moving parts.

Major factors:

  1. Starting weight and metabolic health
    • People with a higher starting BMI often see larger absolute losses (more kilos), though the percentage might be similar.
  1. Dose and duration
    • Ozempic doses for diabetes are usually lower than Wegovy doses used for obesity, so weight loss can be more modest at diabetes doses.
 * Staying on it for at least **6–12 months** matters; the big trial results are over 68 weeks, not 8 weeks.
  1. Lifestyle changes
    • Adding a calorie‑aware eating pattern, more protein, and movement significantly boosts results, and these changes are built into clinical trials.
 * Without lifestyle changes, you can still lose some weight, but usually less and with more risk of regain later.
  1. Side effects and adherence
    • Nausea, vomiting, or stomach issues can lead some people to stop or stay at low doses, limiting weight loss.
 * Others tolerate it well, can titrate to higher doses, and see bigger results.
  1. Time and expectations
    • Healthy, sustainable loss is often around 0.5–1 kg per week at most, and many people lose more slowly than that.
 * Expecting “10 kg in a month” is usually unrealistic and can be unsafe.

Risks, safety, and what it isn’t

Even though it’s a trending topic in 2025–2026, Ozempic isn’t a casual quick‑fix weight‑loss shot.

Important points:

  • Ozempic is approved for type 2 diabetes , not as a cosmetic weight‑loss drug.
  • Wegovy is the semaglutide product specifically approved for obesity and has been studied at higher doses for weight loss.
  • Possible side effects include nausea, vomiting, diarrhea, constipation, gallbladder issues, and rare but serious risks like pancreatitis.
  • Rapid weight loss can also change how your face and skin look (loose skin, “Ozempic face”), which some people find distressing.

Because of all this, experts recommend using these medications under medical supervision, usually as part of a structured obesity or diabetes program rather than DIY weight loss.

If you’re considering Ozempic

If you’re thinking about it for yourself, some practical steps:

  1. Talk to a clinician who knows GLP‑1 meds
    • Especially an endocrinologist or obesity specialist who can look at your full medical picture and other options.
  1. Clarify your goals
    • Think in terms of percentage (for example, 5–10% in the first year) rather than an exact number on the scale.
  1. Plan for the long term
    • Ask what happens if/when you stop: will you taper, switch to another therapy, or focus on lifestyle support to reduce regain.
  1. Build habits alongside the medication
    • Simple, sustainable routines—like regular walks, more protein, less ultra‑processed food—make the drug’s effect more durable.

Quick recap (TL;DR)

  • Many people on semaglutide‑class drugs lose around 10–15% of their starting body weight over 1–1.5 years with lifestyle changes.
  • Individual results range from very modest to 20% or more; it’s not guaranteed and depends on dose, time, and habits.
  • Ozempic itself is for diabetes; weight loss use should be guided by a clinician, with risks and long‑term plans clearly discussed.

Information gathered from public forums or data available on the internet and portrayed here.